Cargando…
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
Traditional 2D cell cultures do not accurately recapitulate tumor heterogeneity, and insufficient human cell lines are available. Patient-derived xenograft (PDX) models more closely mimic clinical tumor heterogeneity, but are not useful for high-throughput drug screening. Recently, patient-derived o...
Autores principales: | Praharaj, Prakash P., Bhutia, Sujit K., Nagrath, Sunitha, Bitting, Rhonda L., Deep, Gagan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054479/ https://www.ncbi.nlm.nih.gov/pubmed/29360544 http://dx.doi.org/10.1016/j.bbcan.2017.12.005 |
Ejemplares similares
-
Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
por: Sankar, Kamya, et al.
Publicado: (2021) -
Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
por: Yang, Jiani, et al.
Publicado: (2021) -
The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
por: Granat, Lauren M., et al.
Publicado: (2019) -
The promise and challenges of precision medicine in dilated cardiomyopathy
por: Mason, Samantha, et al.
Publicado: (2021) -
Human Intestinal Organoids: Promise and Challenge
por: Taelman, Jasin, et al.
Publicado: (2022)